Evidence map›Paper›PMID 34669288›Full record

ArticleBiomedica : revista del Instituto Nacional de Salud2021

Molecular characterization of multiresistant enterobacteria in two departments of the Peruvian jungle

Diana León-Luna, Alexander Fajardo-Loyola, José Yareta-Yareta, Antonio Burgos-Espejo, Carlos Peralta-Siesquen, Marco Galarza-Pérez, Pool Marcos-Carbajal

Abstract read
In one paragraph

Article in Biomedica : revista del Instituto Nacional de Salud, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Whole-Genome Characterisation of ESBL-ProducingAntibiotics (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Diana León-LunaFacultad de Ciencias Naturales y Matemática, Universidad Nacional Federico Villarreal, Lima, Perú. biomedica@ins.gov.co.
Alexander Fajardo-LoyolaFacultad de Ciencias Naturales y Matemática, Universidad Nacional Federico Villarreal, Lima, Perú. biomedica@ins.gov.co.
José Yareta-YaretaUniversidad Peruana Unión, Escuela Profesional Medicina Humana, Laboratorio de Investigación en Biología Molecular, Lima, Perú. biomedica@ins.gov.co.
Antonio Burgos-EspejoSección de Microbiología, Hospital Regional de Pucallpa, Pucallpa, Perú. biomedica@ins.gov.co.
Carlos Peralta-SiesquenLaboratorio de Microbiologia, IPRESS Jorge Chávez, Madre de Dios, Perú. biomedica@ins.gov.co.
Marco Galarza-PérezUniversidad Peruana Unión, Escuela Profesional Medicina Humana, Laboratorio de Investigación en Biología Molecular, Lima, Perú; Laboratorio de Referencia Nacional de Biotecnología y Biología Molecular, Instituto Nacional de Salud, Lima, Perú. biomedica@ins.gov.co.
Pool Marcos-CarbajalUniversidad Peruana Unión, Escuela Profesional Medicina Humana, Laboratorio de Investigación en Biología Molecular, Lima, Perú; Universidad San Martín de Porres, Facultad de Medicina Humana, Centro de Investigación en Medicina Tradicional y Farmacología, Lima, Perú. poolmarcos@upeu.edu.pe.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction. The emergence of multiresistant enterobacteria producing extendedspectrum beta-lactamase (ESBL) in outpatients with urinary tract infections represents a public health problem in Perú. Objectives. To characterize multiresistant enterobacteria isolated from patients diagnosed with urinary tract infection in two Peruvian jungle departments using molecular techniques. Materials and methods. We conducted a descriptive, observational, and retrospective study of 61 urine culture isolates from two departments in the Peruvian jungle during 2017-2018. Resistance profiles were identified using the MicroScan™ automated system and a conventional polymerase chain reaction (PCR) was used for the detection of blaCTX-M, blaTEM and blaSHV genes. Results. The most common positive ESBL enterobacteria for each department were Escherichia coli in Madre de Dios (10/40; 25%) and Ucayali (16/21; 76.2%). Gene blaCTX-M was the most prevalent in both departments (25/61; 41%), followed by blaTEM (15/61; 24.6%), and blaSHV (10/61; 16.4%). As for the antimicrobial susceptibility profile, we detected resistance levels of 72.6% for ampicillin, 82.3% for cephalothin, and 88.7% for nitrofurantoin. Conclusions. BLEE-producing multi-resistant enterobacteria strains in both departments were 57.4% and blaCTX-M was the most common gene.

Indexed as

Escherichia coli InfectionsUrinary Tract InfectionsAnti-Bacterial Agentsbeta-LactamasesEnterobacteriaceaeEscherichia coliHumansMicrobial Sensitivity TestsPeruRetrospective StudiesAnti-Bacterial Agentsbeta-Lactamasesbeta-lactam resistancedrug resistanceEnterobacteriaceaegenesmicrobial

Identifiers

PMID34669288
PMCPMC8724863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.